We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 56

Intellectual property weekly abstracts bulletin week of August 18

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • August 20 2014

In this case, Apotex sought to enter the market with its generic version of travoprost. The Court dismissed the proceeding on the basis that Apotex’

Patent infringement, trade-mark, copyright and Competition Act claims dismissed

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • October 21 2013

In this case, Distrimedic sought a declaration of non-infringement in relation to a kit for the manufacture of a set of individual pill containers

Intellectual property weekly abstracts bulletin

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • July 29 2013

The Federal Court of Appeal has set aside the judgment of the Federal Court, and found that Canadian Patent No. 1,366,777 is valid, and infringed by

Intellectual property weekly abstracts bulletin

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • July 9 2013

Due to a docketing error at the firm of the agent charged with requesting national phase entry of two patent applications, the incorrect fee was paid

Intellectual property weekly abstracts bulletin

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • July 1 2013

Safe Gaming Systems commenced a patent infringement action in the Federal Court in respect of a patent that, according to the statement of claim

Intellectual property weekly abstracts bulletin

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • June 24 2013

The Plaintiffs alleged infringement of two Canadian patents (‘375 and ‘064 Patents) and a Canadian Design Registration (‘793 Design). The Defendants

Intellectual property weekly abstracts bulletin

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • June 3 2013

Bayer sought to prohibit the Minister of Health from issuing a Notice of Compliance to Cobalt for a generic version of Bayer’s oral contraceptive

Intellectual property weekly abstracts bulletin

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • May 13 2013

This case involved a dispute over ownership and alleged infringement of copyright in a number of computer software programs. The Court held that the

Other cases of interest

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 25 2013

As mentioned last week, two IP leave decisions were released last Thursday. Neither appeal obtained leave. The first, Gilead Science Canada Inc. v

Liability for section 8 damages upheld

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 18 2013

AstraZeneca appealed the decision of the Trial Judge with respect to liability for damages pursuant to s. 8 of the NOC Regulations (decision here, our